BUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut

Reuters

12/12

** Diagnostic imaging services provider Lumexa Imaging's LMRI.O shares poised to open slightly above offer price in its Nasdaq debut

** Stock indicated to open at $18.75 apiece vs $18.50 IPO price

** Backed by private equity firm Welsh, Carson, Anderson & Stowe (WCAS), LMRI sold 25 million shares at the midpoint of its marketed range of $17 to $20 per share to raise $462.5 million

** The U.S. IPO market is in the penultimate week of the year with robo-advisor Wealthfront poised to go public in New York on Friday

** Formerly known as US Radiology Specialists, LMRI was formed in 2018 by Charlotte Radiology and WCAS

** LMRI has expanded rapidly in recent years and its U.S. footprint spans 184 centers across 13 states

** Barclays, J.P. Morgan and Jefferies were joint lead book-running managers for offering

(Reporting by Arasu Kannagi Basil in Bengaluru)

((ArasuKannagi.Basil@thomsonreuters.com;))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2590201510"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2590201510\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2590201510?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-12 00:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590201510","market":"nz","top_or_hot":-1,"title":"BUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut</title></head><body><p>** Diagnostic imaging services provider Lumexa Imaging's <span>LMRI.O</span> shares poised to open slightly above offer price in its Nasdaq debut</p><p>** Stock indicated to open at $18.75 apiece vs $18.50 IPO price</p><p>** Backed by private equity firm Welsh, Carson, Anderson &amp; Stowe (WCAS), LMRI <span>sold</span> 25 million shares at the midpoint of its <span>marketed range</span> of $17 to $20 per share to raise $462.5 million</p><p>** The U.S. IPO market is in the penultimate week of the year with robo-advisor Wealthfront poised to go public in New York on Friday</p><p>** Formerly known as US Radiology Specialists, LMRI was formed in 2018 by Charlotte Radiology and WCAS</p><p>** LMRI has expanded rapidly in recent years and its U.S. footprint spans 184 centers across 13 states</p><p>** Barclays, J.P. Morgan and Jefferies were joint lead book-running managers for offering</p><p>(Reporting by Arasu Kannagi Basil in Bengaluru)</p><p>((ArasuKannagi.Basil@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-12-12 00:34</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut</title></head><body><p>** Diagnostic imaging services provider Lumexa Imaging's <span>LMRI.O</span> shares poised to open slightly above offer price in its Nasdaq debut</p><p>** Stock indicated to open at $18.75 apiece vs $18.50 IPO price</p><p>** Backed by private equity firm Welsh, Carson, Anderson &amp; Stowe (WCAS), LMRI <span>sold</span> 25 million shares at the midpoint of its <span>marketed range</span> of $17 to $20 per share to raise $462.5 million</p><p>** The U.S. IPO market is in the penultimate week of the year with robo-advisor Wealthfront poised to go public in New York on Friday</p><p>** Formerly known as US Radiology Specialists, LMRI was formed in 2018 by Charlotte Radiology and WCAS</p><p>** LMRI has expanded rapidly in recent years and its U.S. footprint spans 184 centers across 13 states</p><p>** Barclays, J.P. Morgan and Jefferies were joint lead book-running managers for offering</p><p>(Reporting by Arasu Kannagi Basil in Bengaluru)</p><p>((ArasuKannagi.Basil@thomsonreuters.com;))</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0345777147.USD","symbol_name":"NINETY ONE GSF EUROPEAN EQUITY \"A\" (USD) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nL6N3XH0Z7:1","article_id":"2590201510","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590201510","pubTimestamp":1765470868,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut** Diagnostic imaging services provider Lumexa Imaging's LMRI.O shares poised to open slightly above offer price in its Nasdaq debut** Stock indicated to open at $18.75 apiece vs $18.50 IPO price** Backed by private equity firm Welsh, Carson, Anderson & Stowe , LMRI sold 25 million shares at the midpoint of its marketed range of $17 to $20 per share to raise $462.5 million** The U.S. IPO market is in the penultimate week of the year with robo-advisor Wealthfront poised to go public in New York on Friday** Formerly known as US Radiology Specialists, LMRI was formed in 2018 by Charlotte Radiology and WCAS** LMRI has expanded rapidly in recent years and its U.S. footprint spans 184 centers across 13 states** Barclays, J.P. Morgan and Jefferies were joint lead book-running managers for offering","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0345777147.USD":"NINETY ONE GSF EUROPEAN EQUITY \"A\" (USD) ACC","AMSF":"Amerisafe Inc","LU1023061713.HKD":"BGF EUROPEAN VALUE \"A2\" (HKDHDG) ACC","LU1078025761.USD":"NINETY ONE GSF EUROPEAN EQUITY \"A\" (USDHDG) ACC","LU1035777561.USD":"AB SICAV I - EUROPEAN EQUITY PORTFOLIO \"A\" (USDHDG) ACC","LU0047473722.EUR":"HSBC GIF EUROPE VALUE \"PD\" (EUR) INC","LU0048578792.EUR":"FIDELITY EUROPEAN GROWTH \"A\" INC","LU0106831901.USD":"贝莱德世界金融基金A2","BK4107":"财产与意外伤害保险","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU0171281750.USD":"BGF EUROPEAN VALUE \"A2\" (USD) ACC","LU1023061473.USD":"BGF EUROPEAN VALUE \"A2\" (USD HDG) ACC","LU0161305163.EUR":"SCHRODER ISF EUROPEAN VALUE \"A\" (EUR) ACC","LMRI":"Lumexa Imaging Holdings","BARC.UK":"巴克莱银行","LU1064927863.SGD":"JPMorgan Funds - Europe Dynamic A (acc) SGD-H","LU0345777659.USD":"NINETY ONE GSF EUROPEAN EQUITY \"A\" (USD) INC","LU0047473722.SGD":"HSBC GIF EUROPE VALUE \"PD\" (SGD) INC","LU0550127509.SGD":"富达欧洲增长基金SGD","LU1791807156.HKD":"BGF WORLD FINANCIALS \"A2\" (HKDHDG) ACC","BK5152":"综合性银行","LU0997586606.USD":"FIDELITY EUROPEAN GROWTH \"A\" (USDHDG) ACC","LU0964806797.USD":"UBS (LUX) EQUITY FUND - EUROPEAN OPPORTUNITY SUSTAINABLE (EUR) \"P\" (USHDG) ACC","LU0987226296.USD":"JPM EUROPE DYNAMIC  \"A\" (USDHEDGED) ACC","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU2646069778.SGD":"JPM EUROPE DYNAMIC \"A\" (SGD) ACC"},"translate_title":"BUZZ-Welsh Carson支持的Lumexa Imaging准备在纳斯达克低调亮相","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LMRI":0.9,"BARC.UK":0.9,"AMSF":0.9},"content_text":"BUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut** Diagnostic imaging services provider Lumexa Imaging's LMRI.O shares poised to open slightly above offer price in its Nasdaq debut** Stock indicated to open at $18.75 apiece vs $18.50 IPO price** Backed by private equity firm Welsh, Carson, Anderson & Stowe (WCAS), LMRI sold 25 million shares at the midpoint of its marketed range of $17 to $20 per share to raise $462.5 million** The U.S. IPO market is in the penultimate week of the year with robo-advisor Wealthfront poised to go public in New York on Friday** Formerly known as US Radiology Specialists, LMRI was formed in 2018 by Charlotte Radiology and WCAS** LMRI has expanded rapidly in recent years and its U.S. footprint spans 184 centers across 13 states** Barclays, J.P. Morgan and Jefferies were joint lead book-running managers for offering(Reporting by Arasu Kannagi Basil in Bengaluru)((ArasuKannagi.Basil@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}